Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Choose more journals

Article type Check one or more article types to show results from those article types only.
Subject Check one or more subjects to show results from those subjects only.
Date Choose a date option to show results from those dates only.

Custom date range

Clear all filters
Sort by:
Showing 1–2 of 2 results
Advanced filters: Author: "Robert L Sutherland" Clear advanced filters

  • Is the ability of D-type cyclins to activate cyclin-dependent kinases an effective means of targeting these oncogenes, and how might the patient subgroups that are most likely to benefit be identified?

    • Elizabeth A. Musgrove
    • C. Elizabeth Caldon
    • Robert L. Sutherland
    Reviews
    Nature Reviews Cancer
    Volume: 11, P: 558-572

  • The efficacy of endocrine therapies (such as tamoxifen) in breast cancer is limited by intrinsic and acquired therapeutic resistance. What do we know about the genetic lesions and molecular processes that determine endocrine resistance in the clinic, and how can we use this to improve therapy?

    • Elizabeth A. Musgrove
    • Robert L. Sutherland
    Reviews
    Nature Reviews Cancer
    Volume: 9, P: 631-643